We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
HCA Healthcare (HCA) Q2 Earnings and Revenues Miss Estimates
Read MoreHide Full Article
Have you been eager to see how HCA Healthcare, Inc. (HCA - Free Report) performed in Q2 in comparison with the market expectations?
Let’s quickly scan through the key facts from this leading hospital company’s earnings release this morning.
An Earnings Miss
HCA Healthcare came out with adjusted earnings per share of $1.77, missing the Zacks Consensus Estimate of $1.80.
The earnings miss was driven by growth in expenses which outpaced revenue growth.
How Was the Estimate Revision Trend?
The earnings estimate revisions for HCA Healthcare did not show a major change prior to the earnings release. But the same has gone down by 0.5% over the past 30 days.
Before posting earnings miss in Q2, the company delivered positive surprises in each three of the trailing four quarters.
As a result, the company overall surpassed the Zacks Consensus Estimate by an average of 4.3% in the trailing four quarters.
HCA Healthcare posted revenues of $10.73 billion, a tad lower than the Zacks Consensus Estimate of $10.74 billion. The reported figure was up from 4% from the year-ago quarter.
Key Stats to Note
Adjusted EBITDA totaled $2.090 billion up 1.9% year over year.
Same facility equivalent admissions increased 1.3% year over year, while same facility admissions increased 0.8%. Same facility revenue per equivalent admission increased 2%.
Salaries and benefits, supplies and other operating expenses totaled $8.656 billion up 4.6% year over year.
As of Jun 30, 2017, HCA Healthcare operated 172 hospitals and 119 freestanding surgery centers.
Guidance Update
The company updated its 2017 earnings guidance. It expects revenues in the range of $43 billion -$44 billion, adjusted EBIDTA of $ 8.35–$8.50, EPS of $7.00–$7.30 and capital expenditures of nearly $2.9 billion.
Check back later for our full write up on this HCA Healthcare earnings report!
More Stock News: Tech Opportunity Worth $386 Billion in 2017 From driverless cars to artifical intelligence, we've seen an unsurpassed growth of high-tech products in recent months. Yesterday's science-fiction is becoming today's reality. Despite all the innovation, there is a single component no tech company can survive without. Demand for this critical device will reach $387 billion this year alone, and it's likely to grow even faster in the future. Zacks has released a brand-new Special Report to help you take advantage of this exciting investment opportunity. Most importantly, it reveals 4 stocks with massive profit potential. See these stocks now>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
HCA Healthcare (HCA) Q2 Earnings and Revenues Miss Estimates
Have you been eager to see how HCA Healthcare, Inc. (HCA - Free Report) performed in Q2 in comparison with the market expectations?
Let’s quickly scan through the key facts from this leading hospital company’s earnings release this morning.
An Earnings Miss
HCA Healthcare came out with adjusted earnings per share of $1.77, missing the Zacks Consensus Estimate of $1.80.
The earnings miss was driven by growth in expenses which outpaced revenue growth.
How Was the Estimate Revision Trend?
The earnings estimate revisions for HCA Healthcare did not show a major change prior to the earnings release. But the same has gone down by 0.5% over the past 30 days.
Before posting earnings miss in Q2, the company delivered positive surprises in each three of the trailing four quarters.
As a result, the company overall surpassed the Zacks Consensus Estimate by an average of 4.3% in the trailing four quarters.
HCA Holdings, Inc. Price and EPS Surprise
HCA Holdings, Inc. Price and EPS Surprise | HCA Holdings, Inc. Quote
Revenue a Tad Lower
HCA Healthcare posted revenues of $10.73 billion, a tad lower than the Zacks Consensus Estimate of $10.74 billion. The reported figure was up from 4% from the year-ago quarter.
Key Stats to Note
Adjusted EBITDA totaled $2.090 billion up 1.9% year over year.
Same facility equivalent admissions increased 1.3% year over year, while same facility admissions increased 0.8%. Same facility revenue per equivalent admission increased 2%.
Salaries and benefits, supplies and other operating expenses totaled $8.656 billion up 4.6% year over year.
As of Jun 30, 2017, HCA Healthcare operated 172 hospitals and 119 freestanding surgery centers.
Guidance Update
The company updated its 2017 earnings guidance. It expects revenues in the range of $43 billion -$44 billion, adjusted EBIDTA of $ 8.35–$8.50, EPS of $7.00–$7.30 and capital expenditures of nearly $2.9 billion.
What Zacks Rank Says
HCA Healthcare carries a Zacks Rank #3 (Hold). However, since the latest earnings performance is yet to be reflected in the estimate revisions, the rank is subject to change. (You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here).
Check back later for our full write up on this HCA Healthcare earnings report!
More Stock News: Tech Opportunity Worth $386 Billion in 2017
From driverless cars to artifical intelligence, we've seen an unsurpassed growth of high-tech products in recent months. Yesterday's science-fiction is becoming today's reality. Despite all the innovation, there is a single component no tech company can survive without. Demand for this critical device will reach $387 billion this year alone, and it's likely to grow even faster in the future. Zacks has released a brand-new Special Report to help you take advantage of this exciting investment opportunity. Most importantly, it reveals 4 stocks with massive profit potential. See these stocks now>>